Guishao Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guishao Tang has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Siying Li
2 shared publicationsSuhan Zhang
Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China
2 shared publicationsYanshan Zhu
2 shared publications- Bin Hu
Department of Dermatology, Wuhan No. 1 Hospital, Wuhan, China
1 shared publication - Bin Yang
Dermatology Hospital, Southern Medical University, Guangzhou, China
1 shared publication Bingyi Yang
Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China
1 shared publication
Latest Publications
- 15 April 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (12) , 2268-2279
Human‐multimodal deep learning collaboration in ‘precise’ diagnosis of lupus erythematosus subtypes and similar skin diseases
Background: Lupus erythematosus (LE) is a spectrum of autoimmune diseases. Due to the complexity of cutaneous LE (CLE), clinical skin image‐based artificial intelligence is still experiencing difficulties in distinguishing subtypes of LE.Objectives: We aim to develop a multimodal deep learning system (MMDLS) for human‐AI collaboration in diagnosis of LE subtypes.Methods: This is a multi‐centre study based on 25 institutions across China to assist in diagnosis of LE subtypes, other eight similar skin diseases and healthy subjects. In total, 446 cases with 800 clinical skin images, 3786 multicolor‐immunohistochemistry (multi‐IHC) images and clinical data were collected, and EfficientNet‐B3 and ResNet‐18 were utilized in this study.Results: In the multi‐classification task, the overall performance of MMDLS on 13 skin conditions is much higher than single or dual modals (Sen = 0.8288, Spe = 0.9852, Pre = 0.8518, AUC = 0.9844). Further, the MMDLS‐based diagnostic‐support help improves the accuracy of dermatologists from 66.88% ± 6.94% to 81.25% ± 4.23% (p = 0.0004).Conclusions: These results highlight the benefit of human‐MMDLS collaborated framework in telemedicine by assisting dermatologists and rheumatologists in the differential diagnosis of LE subtypes and similar skin diseases.
- 15 April 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (12) , 2268-2279
Human‐multimodal deep learning collaboration in ‘precise’ diagnosis of lupus erythematosus subtypes and similar skin diseases
Background: Lupus erythematosus (LE) is a spectrum of autoimmune diseases. Due to the complexity of cutaneous LE (CLE), clinical skin image‐based artificial intelligence is still experiencing difficulties in distinguishing subtypes of LE.Objectives: We aim to develop a multimodal deep learning system (MMDLS) for human‐AI collaboration in diagnosis of LE subtypes.Methods: This is a multi‐centre study based on 25 institutions across China to assist in diagnosis of LE subtypes, other eight similar skin diseases and healthy subjects. In total, 446 cases with 800 clinical skin images, 3786 multicolor‐immunohistochemistry (multi‐IHC) images and clinical data were collected, and EfficientNet‐B3 and ResNet‐18 were utilized in this study.Results: In the multi‐classification task, the overall performance of MMDLS on 13 skin conditions is much higher than single or dual modals (Sen = 0.8288, Spe = 0.9852, Pre = 0.8518, AUC = 0.9844). Further, the MMDLS‐based diagnostic‐support help improves the accuracy of dermatologists from 66.88% ± 6.94% to 81.25% ± 4.23% (p = 0.0004).Conclusions: These results highlight the benefit of human‐MMDLS collaborated framework in telemedicine by assisting dermatologists and rheumatologists in the differential diagnosis of LE subtypes and similar skin diseases.
- Open Access
- 19 February 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 160
Auranofin ameliorates psoriasis-like dermatitis in an imiquimod-induced mouse by inhibiting of inflammation and upregulating FA2H expression
- 19 February 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 160
Open AccessAuranofin ameliorates psoriasis-like dermatitis in an imiquimod-induced mouse by inhibiting of inflammation and upregulating FA2H expression
- 21 December 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 49 (4) , 432-440
Decreased microRNA‐126 expression in psoriatic CD4 + T cells promotes T‐helper 17 cell differentiation and the formation of dermatitis in imiquimod‐induced psoriasis‐like mice
Psoriasis is a chronic inflammatory skin disease with multiple genetic backgrounds, whose etiology and pathogenesis are still unclear. Complex T-cell immune imbalance has been demonstrated to play an important role in pathogenesis of psoriasis. This study reported that microRNA-126 (miR-126) expression was decreased in CD4+ T cells of both psoriasis patients and psoriasis-like mouse models and its expression was negatively correlated with the Psoriasis Area and Severity Index (PASI) score of psoriasis patients. Conditional Mir126 knockout in mouse CD4+ T cells can obviously aggravate the psoriasis-like dermatitis and promote T-helper (Th)1 and Th17 cells’ infiltration in spleen of imiquimod (IMQ)-induced psoriasis-like mouse model. In addition, the mRNA expression of Il17a and Il17f were significantly increased in mouse naïve CD4+ T cells with Mir126 knockout after stimulating with CD3 and CD28. Compared with naïve CD4+ T cells, the expression of Mir126 was decreased in Th17 cells, and Mir126 knockout notably promoted the differentiation of naïve CD4+ T cells to Th17 cells as well as the mRNA expression of Il17a, Il17f, Rorc, and Il23R. Our results revealed that decreased miR-126 in psoriatic CD4+ T cells might accelerate the formation of skin lesions through promoting the differentiation of Th17 cells, thus suggesting a potential intervention target for psoriasis.
- 21 December 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 49 (4) , 432-440
Decreased microRNA‐126 expression in psoriatic CD4 + T cells promotes T‐helper 17 cell differentiation and the formation of dermatitis in imiquimod‐induced psoriasis‐like mice
Psoriasis is a chronic inflammatory skin disease with multiple genetic backgrounds, whose etiology and pathogenesis are still unclear. Complex T-cell immune imbalance has been demonstrated to play an important role in pathogenesis of psoriasis. This study reported that microRNA-126 (miR-126) expression was decreased in CD4+ T cells of both psoriasis patients and psoriasis-like mouse models and its expression was negatively correlated with the Psoriasis Area and Severity Index (PASI) score of psoriasis patients. Conditional Mir126 knockout in mouse CD4+ T cells can obviously aggravate the psoriasis-like dermatitis and promote T-helper (Th)1 and Th17 cells’ infiltration in spleen of imiquimod (IMQ)-induced psoriasis-like mouse model. In addition, the mRNA expression of Il17a and Il17f were significantly increased in mouse naïve CD4+ T cells with Mir126 knockout after stimulating with CD3 and CD28. Compared with naïve CD4+ T cells, the expression of Mir126 was decreased in Th17 cells, and Mir126 knockout notably promoted the differentiation of naïve CD4+ T cells to Th17 cells as well as the mRNA expression of Il17a, Il17f, Rorc, and Il23R. Our results revealed that decreased miR-126 in psoriatic CD4+ T cells might accelerate the formation of skin lesions through promoting the differentiation of Th17 cells, thus suggesting a potential intervention target for psoriasis.